APPLICATIONS PUBLISHED 17 AUGUST 2005
Depot formulations of arylheterocyclic active agents in the form of a suspension
Pfizer Products 1562546*
Method of stimulating hair growth using benzopyrans
Warner-Lambert 1562547*
Oral testosterone delivery system with improved sustained release
Shear/Kershman Laboratories 1562548*
High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compsns containing them
Pevion Biotech 1562550*
Controlled release carvediol compsns
Egalet 1562552*
Methods of providing controlled release pharmaceutical comspsn and controlled-release pharmaceutical compsn
Barr Laboratories 1562553*
A method for normalising insulin levels
Quality Vitamins; Chapnick, David Linda 1562554*
Sustained release -arginine formulations and methods of manufacture and use
Enos Pharmaceuticals 1562555*
Pharmaceutical compsns and dosage forms of thalidomine
Celgene 1562556*
Geodate delivery vehicles
Biodelivery Sciences International 1562557*
Palatable micro-capsules
Micap 1562558*
Biodegradable colloid particles, in particular for pulmonary applications
Transmit Gesellschaft fuer Technologietransfer; Justus-Liebig-Universitaet Giessen; Philipps-Universitaet Marburg 1562559*
Modified release compsns comprising a short-acting hypnotic for treatment of sleep disorders
Elan Pharmaceuticals 1562560*
Stable aerosol formulation of peptides and proteins with non-CFC propellants
Medpharm 1562561*
Methods for treatment of thiol-containing compound deficient conditions
National Jewish Medical Research Centre 1562563*
Combination cancer therapy with a GST-activated anticancer compound and another anti-cancer therapy
Telik 1562564*
Use of one or more elements from the group containing yttrium, neodymium and zirconium
Biotronik 1562565*
Analgesic compsns comprising NMDA receptor antagonists and benzalkonium chloride
Innovative Drug Delivery Systems 1562566*
Combination of selected analgesics and COX-11 inhibitors
Gruenenthal 1562567*
Treatment of heaves
Ciofalo, Vincent 1562586*
Antifungal medicaments comprising arylamidine derivatives
Bayer CropScience 1562569*
Treatment of amyotrophic lateral sclerosis with nimesulide
Mount Sinai School of Medicine 1562570*
Combination of diamine derivatives and immunosuppresive agents for the induction of immune tolerance
Genzyme Corp 1562571*
Pharmaceutical solutions of modafinil compounds
Cephalon 1562572*
Pharmaceutical pellets comprising tamsulosin and a process for making the same
Synthon 1562573*
2-oxo-ethanesulphonamide derivatives
AstraZeneca 1562574*
Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of I.A. epilepsy
Abbott Laboratories 1562575*
Enhancement of alcohol metabolism
Remedal 1562576*
Acetyl-L-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents
SIGMA-TAU Industrie Farmaceutiche Riunite 1562577*
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
Hemocorm 1562578*
Therapeutic delivery of carbon monoxide
Hemocorm 1562579*
Intermediates for aromatic polyketides as selective anticancer and antiviral agents
Galilaeus 1562580*
Pharmaceutical compsn comprising cannabinoids for the treatment of pain and sleep disorders
GW Pharma 1562581*
Cholesterol absorption inhibitors for the treatment of demyelination
Schering 1562582*
Atorvastatin calcium form IV or hydrates thereof
Morepen Laboratories 1562583*
Novel hydroxyindoles, use as inhibitors of phosphodiesterase 4 and method for production thereof
Elbion 1562584*
Daily melatonin dosing units
Asat 1562585*
Methods of using and compsns comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
Celgene 1562586*
Novel compsns and methods for the treatment of immune related diseases
Genentech 1562587*
Use of PDE inhibitors as adjunct therapy for psychiatric disorders
Merck 1562588*
Diaminotriazoles useful as inhibitors of protein kinases
Vertex Pharmaceuticals 1562589*
Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls
The Regents of the University of California 1562590*
Treatment of mesothelioma
Novartis 1562591*
Histone deacetylase inhibitors for treating degenerative diseases of the eye
Alcon 1562592*
Topoisomerase-targeting agents
Rutgers, The State University of New Jersey; Lavoie, Edmond 1562593*
Methylene-bridged selective androgen receptor modulators and methods of use thereof
University of Tennessee Research Foundation 1562594*
Diaryl ethers as opioid receptor antagonists
Eli Lilly 1562595*
Derivatives of pyridinalkyl-amonoalkyl-1H-indole inhibiting receptors 5-HT and recapture of serotonin which can be used as antidepressant and anxiolytic
Merck Patent 1562596*
Methods of using and compsns comprising immunomodulatory compounds for treatment and management of macular degeneration
Celgene 1562597*
Derivatives of gambogic acid and analogues as activators of caspases and inducers of apoptosis
Cytovia 1562598*
Quaternary ammonium compounds as muscarinic receptor antagonists
Pharmacia & Upjohn 1562599*
Combination administration of an indoline with a chemotherapeutic agent for cell proliferation disorders
Sugen 1562600*
Combination chemotherapy comprising a MEK inhibitor and capecitabine for treating cancer
Warner-Lambert 1560601*
Immediate release topical pharmaceutical formulation for enhancement of female sexual desire and responsiveness
Vivus 1562602*
Novel medicaments for the treatment of chronic obstructive pulmonary diseases
Boehringer Ingelheim Pharma 1562603*
Prostaglandin compounds for the treatment of obesity
Sucampo 1562604*
Compounds for modulation of cholesterol transport
Massachusetts Institute of Technology; Institute for Blood Research 1562605*
Method of using vitamin D compounds in the treatment of myelodysplastic syndromes
Novacea 1562606*
Pharmaceutical dosage forms of biguanide-sulphonylurea combinations
Ranbaxy Laboratories 1562607*
Methods of using substituted tetracycline compounds to modulate RNA
Paratek Pharmaceuticals 1562608*
Inositolised phospholipids
Charite-Universitaetsmedizin Berlin 1562609*
Combination therapy with gemcitabine and ZD6126
Angiogene Pharmaceuticals 1562610*